Immunovia AB
IMMNOV
Rang in aandelen
#34471
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for... Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Aandeelprijs
$0.00761318
Marktkapitalisatie
$5.12M
Verandering (1 dag)
-0.79%
Verandering (1 jaar)
-85.38%
Land
SE
Handel Immunovia AB (IMMNOV)
Categorie
Healthcare
Koersgeschiedenis voor Immunovia AB (IMMNOV)
Hoogste slotkoers: $0.01 op 2026-10-01
Laagste slotkoers: $6.16 op 2019-06-01
Laagste slotkoers: $6.16 op 2019-06-01
Koersgeschiedenis van Immunovia AB van 2019 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -50.09% |
| 2025 | -2.79% |
| 2024 | -50.93% |
| 2023 | -90.35% |
| 2022 | -60.80% |
| 2021 | -55.60% |
| 2020 | 0.32% |
| 2019 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
